Sandbox:Ascites DD: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (12 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
==Genes== | |||
TMEM67 | |||
TTC21B | |||
WDR19 | |||
ZNF423 | |||
CEP164 | |||
ANKS6 | |||
INPP5E | |||
TMEM216 | |||
AHI1 | |||
NPHP1 | |||
CEP290 | |||
RPGRIP1L | |||
ARL13B | |||
CC2D2A | |||
OFD1 | |||
TTC21B | |||
KIF7 | |||
TCTN1 | |||
CEP41 | |||
TMEM138 | |||
C5orf42 | |||
TCTN3 | |||
ZNF423 | |||
TMEM231 | |||
TCTN2 | |||
BBS1 | |||
BBS2 | |||
ARL6 | |||
BBS4 | |||
BBS5 | |||
MKKS | |||
BBS7 | |||
TTC8 | |||
BBS9 | |||
BBS10 | |||
TRIM32 | |||
BBS12 | |||
MKS1 | |||
CEP290 | |||
MKS1 | |||
CC2D2A | |||
NPHP3 | |||
B9D1 | |||
B9D2 | |||
IFT122 | |||
EVC | |||
EVC2 | |||
IFT80 | |||
OFD1 | |||
PKD1 | |||
PKD2 | |||
Timp1 | |||
CALHM1 | |||
GST01 | |||
PAX1P1 | |||
PLD3 | |||
TOMM40 | |||
UNC5C | |||
SLC24A4 | |||
PTK2B | |||
ZCWPW1 | |||
CELF1 | |||
FERMT2 | |||
CASS4 | |||
INPP5D | |||
NME8 | |||
UBQLN1 | |||
GSD 1 | |||
GSD type 1a | |||
GSD type 1b | |||
FAM111A | |||
CHD7 | |||
G744S | |||
AIRE | |||
===Chromosome 1 == | |||
'''p-arm''' | |||
The following are some of the genes located on p-arm (short arm) of human chromosome 1: | |||
* AADACL3 | |||
* AADACL4 | |||
* ACADM | |||
* ACTL8 | |||
* AMPD2 | |||
* ATXN7L2 | |||
* AZIN2 | |||
* BCAS2 | |||
* C1orf103 | |||
* C1orf109 | |||
* C1orf123 | |||
* CASZ1 | |||
* CMPK | |||
* COL11A1 | |||
* CPT2 | |||
* CRYZ | |||
* CSDE1 | |||
* DBT | |||
* DCLRE1B | |||
* DEPDC1 | |||
* DIRAS3 | |||
* DPH5 | |||
* ESPN | |||
* EVI5 | |||
* EXTL1 | |||
* EXTL2 | |||
* FAM46B | |||
* FAM46C | |||
* FAM76A | |||
* FBXO2 | |||
* FPGT | |||
* GALE | |||
* GBP2 | |||
* GJB3 | |||
* GNL2 | |||
* HES2 | |||
* HES3 | |||
* HMGCL | |||
* HAO2 | |||
* HMGCS2 | |||
* HP1BP3 | |||
* IFI6 | |||
* INTS11 | |||
* KCNQ4 | |||
* KIF1B | |||
* L1TD1 | |||
* LRRC39 | |||
* LRRC40 | |||
* LRRC41 | |||
* LRRC8D | |||
* MAN1A2 | |||
* MEAF | |||
* MECR | |||
* MFAP2 | |||
* MFN2 | |||
* MFSD2 | |||
* MIR6079 | |||
* MMEL1 | |||
* MTFR1L | |||
* MTHFR | |||
* MUL1 | |||
* MUTYH | |||
* NBPF3 | |||
* NGF | |||
* NOL9 | |||
* OLFML3 | |||
* OMA1 | |||
* OVGP1 | |||
* PARK7 | |||
* PINK1 | |||
* PLOD1 | |||
* PRMT6 | |||
* PSRC1 | |||
* RAD54 | |||
* RCC2 | |||
* RHBDL2 | |||
* RLF | |||
* RNF220 | |||
* SDC3 | |||
* SGIP1 | |||
* SH3BGRL3 | |||
* SPSB1 | |||
* SYCP1 | |||
* SZT2 | |||
* TACSTD2 | |||
* TCEB3 | |||
* TMCO4 | |||
* TMEM48 | |||
* TMEM50A | |||
* TMEM59 | |||
* TMEM69 | |||
* TMEM222 | |||
* TOE1 | |||
* TRAPPC3 | |||
* TRIT1 | |||
* TSHB | |||
* TTC39A | |||
* UBR4 | |||
* UROD | |||
* USP48 | |||
* VPS13D | |||
* WARS2 | |||
* ZCCHC17 | |||
* ZMYM1 | |||
* ZNF436 | |||
* ZZZ3 | |||
'''q arm''' | |||
* AHCTF1 | |||
* ANGPTL1 | |||
* ARID4B | |||
* ASPM | |||
* C1orf21 | |||
* C1orf35 | |||
* C1orf49 | |||
* C1orf74 | |||
* C1orf106 | |||
* CD5L | |||
* CENPL | |||
* CHTOP | |||
* CNIH4 | |||
* CNST | |||
* CREG1 | |||
* CRP | |||
* CSRP1 | |||
* DDX59 | |||
* DPT | |||
* DNAH14 | |||
* EDEM3 | |||
* F5 | |||
* FAM20B | |||
* FAM63A | |||
* FAM78B | |||
* FAM129A | |||
* FBXO28 | |||
* FCMR | |||
* FMO3 | |||
* GBA | |||
* GBAP1 | |||
* GLC1A | |||
* GON4L | |||
* HEATR1 | |||
* HFE2 | |||
* HIST2H2AB | |||
* HIST2H2BF | |||
* HIST2H3PS2 | |||
* HIST3H2A | |||
* HIST3H2BB | |||
* HPC1 | |||
* INTS3 | |||
* IRF6 | |||
* LEFTY1 | |||
* LMNA | |||
* LYPLAL1 | |||
* MIR194-1 | |||
* MIR5008 | |||
* MPC2 | |||
* MOSC1 | |||
* MOSC2 | |||
* MPZ | |||
* MSTO1 | |||
* NAV1 | |||
* NBPF1 | |||
* NOC2L | |||
* NUCKS1 | |||
* NVL | |||
* OLFML2B | |||
* OPTC | |||
* OTUD7B | |||
* PGDB5 | |||
* PI4KB | |||
* PIP5K1A | |||
* PPOX | |||
* PRR9 | |||
* PSEN2 | |||
* RABIF | |||
* RN5S1 | |||
* SCAMP3 | |||
* SDHB | |||
* SLC50A1 | |||
* SMCP | |||
* SMG7 | |||
* SPRR1A | |||
* SPRR1B | |||
* SPRR2A | |||
* SPRTN | |||
* TARBP1 | |||
* TBCE | |||
* THBS3 | |||
* TMCO1 | |||
* TMEM9 | |||
* TMEM63A | |||
* TNNT2 | |||
* TOR1AIP1 | |||
* UAP1 | |||
* USH2A | |||
* VPS45 | |||
* VPS72 | |||
* YY1AP1 | |||
* ZBED6 | |||
* ZC3H11A | |||
* ZNF687 | |||
* ZNF648 | |||
* ZNF695 | |||
===Preferred Table=== | ===Preferred Table=== | ||
{| | {| | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! colspan="2" rowspan="2" |Diseases | ! colspan="2" rowspan="2" |Diseases | ||
! colspan=" | ! colspan="4" |History and Symptoms | ||
| | | | ||
| | ! colspan="5" |Physical Examination | ||
| colspan="3" |Laboratory Findings | |||
! rowspan="2" |Other Findings | ! rowspan="2" |Other Findings | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
!Fever | !Fever | ||
!Icterus | !Icterus | ||
!Abdominal pain | !Abdominal pain | ||
!Peripheral edema | !Peripheral edema | ||
!Chest pain | !Chest pain | ||
!Jugular vein distension | !Jugular vein distension | ||
!Hepatomegaly | |||
!Skin rash | !Skin rash | ||
!Edema | !Edema | ||
!Spider angiomata | !Spider angiomata | ||
!Serum to ascites albumin gradient | !Serum to ascites albumin gradient (SAAG) | ||
! | !Ascitic fluid: | ||
* Exudative Vs Transudative | |||
! | * General appearance | ||
!CBC | |||
|- | |- | ||
| rowspan="4" style="background: #F5F5F5; padding: 5px;" |''' | | rowspan="4" style="background: #F5F5F5; padding: 5px;" |'''Hepatic causes''' | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cirrhosis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cirrhosis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | rowspan="4" style="background: #F5F5F5; padding: 5px;" | ≥1.1 | ||
| | | rowspan="4" style="background: #F5F5F5; padding: 5px;" | | ||
*Transudate | |||
* Opalescent | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Budd chiari syndrome | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Budd chiari syndrome | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Acute liver failure | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Acute liver failure | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Alcoholic hepatitis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Alcoholic hepatitis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | + | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 96: | Line 370: | ||
| rowspan="3" style="background: #F5F5F5; padding: 5px;" |'''GI causes''' | | rowspan="3" style="background: #F5F5F5; padding: 5px;" |'''GI causes''' | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Whipple disease | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Whipple disease | ||
| style="background: #F5F5F5; padding: 5px;" | + | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | + | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" |<1.1 | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Transudate | |||
* Clear | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Peritonitis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Peritonitis | ||
| style="background: #F5F5F5; padding: 5px;" | + | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | + | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | ≥1.1 or <1.1 | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Exudate | |||
* Turbid or cloudy | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Pancreatitis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Pancreatitis | ||
| style="background: #F5F5F5; padding: 5px;" | + (Severe pancreatitis) | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | + (In rare cases) | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" |<1.1 | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Exudate | |||
*Turbid or cloudy | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Amylase level >100 units/L in the ascitic fluid | ||
|- | |- | ||
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |'''Cardiac causes''' | | rowspan="2" style="background: #F5F5F5; padding: 5px;" |'''Cardiac causes''' | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |CHF | | style="background: #DCDCDC; padding: 5px; text-align: center;" |CHF | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + (In Rt heart failure) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |≥1.1 | ||
| | | rowspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
* Transudate | |||
* Clear | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Pericarditis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Pericarditis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | ≥1.1 | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 183: | Line 459: | ||
| style="background: #F5F5F5; padding: 5px;" |'''Renal cause''' | | style="background: #F5F5F5; padding: 5px;" |'''Renal cause''' | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Nephrotic syndrome | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Nephrotic syndrome | ||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | + | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | + | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" |<1.1 | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Transudate | |||
* | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 201: | Line 478: | ||
| rowspan="5" style="background: #F5F5F5; padding: 5px;" |'''Other causes''' | | rowspan="5" style="background: #F5F5F5; padding: 5px;" |'''Other causes''' | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sarcoidosis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Sarcoidosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 218: | Line 494: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |SLE | | style="background: #DCDCDC; padding: 5px; text-align: center;" |SLE | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 235: | Line 510: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |TB | | style="background: #DCDCDC; padding: 5px; text-align: center;" |TB | ||
| style="background: #F5F5F5; padding: 5px;" | + | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | + | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | + (In Cutaneous TB) | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | ≥1.1 or <1.1 | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Exudate | |||
* Turbid | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hypothyroidism | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Hypothyroidism | ||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | + (Myxedematous edema) | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | + (Myxedematous edema) | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Transudate | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Low TSH level | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cancer | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cancer | ||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | +/- | |||
| style="background: #F5F5F5; padding: 5px;" | +/- | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | +/- | |||
| style="background: #F5F5F5; padding: 5px;" | ≥1.1 | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Transudate | |||
* Bloody | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Tumor markers for determination of the cancer type | ||
|} | |} | ||
Latest revision as of 17:14, 30 November 2017
Genes
TMEM67 TTC21B WDR19 ZNF423 CEP164 ANKS6 INPP5E TMEM216 AHI1 NPHP1 CEP290 RPGRIP1L ARL13B CC2D2A OFD1 TTC21B KIF7 TCTN1 CEP41 TMEM138 C5orf42 TCTN3 ZNF423 TMEM231 TCTN2 BBS1 BBS2 ARL6 BBS4 BBS5 MKKS BBS7 TTC8 BBS9 BBS10 TRIM32 BBS12 MKS1 CEP290 MKS1 CC2D2A NPHP3 B9D1 B9D2 IFT122 EVC EVC2 IFT80 OFD1 PKD1 PKD2 Timp1 CALHM1 GST01 PAX1P1 PLD3 TOMM40 UNC5C SLC24A4 PTK2B ZCWPW1 CELF1 FERMT2 CASS4 INPP5D NME8 UBQLN1 GSD 1 GSD type 1a GSD type 1b FAM111A CHD7 G744S AIRE
=Chromosome 1
p-arm The following are some of the genes located on p-arm (short arm) of human chromosome 1:
- AADACL3
- AADACL4
- ACADM
- ACTL8
- AMPD2
- ATXN7L2
- AZIN2
- BCAS2
- C1orf103
- C1orf109
- C1orf123
- CASZ1
- CMPK
- COL11A1
- CPT2
- CRYZ
- CSDE1
- DBT
- DCLRE1B
- DEPDC1
- DIRAS3
- DPH5
- ESPN
- EVI5
- EXTL1
- EXTL2
- FAM46B
- FAM46C
- FAM76A
- FBXO2
- FPGT
- GALE
- GBP2
- GJB3
- GNL2
- HES2
- HES3
- HMGCL
- HAO2
- HMGCS2
- HP1BP3
- IFI6
- INTS11
- KCNQ4
- KIF1B
- L1TD1
- LRRC39
- LRRC40
- LRRC41
- LRRC8D
- MAN1A2
- MEAF
- MECR
- MFAP2
- MFN2
- MFSD2
- MIR6079
- MMEL1
- MTFR1L
- MTHFR
- MUL1
- MUTYH
- NBPF3
- NGF
- NOL9
- OLFML3
- OMA1
- OVGP1
- PARK7
- PINK1
- PLOD1
- PRMT6
- PSRC1
- RAD54
- RCC2
- RHBDL2
- RLF
- RNF220
- SDC3
- SGIP1
- SH3BGRL3
- SPSB1
- SYCP1
- SZT2
- TACSTD2
- TCEB3
- TMCO4
- TMEM48
- TMEM50A
- TMEM59
- TMEM69
- TMEM222
- TOE1
- TRAPPC3
- TRIT1
- TSHB
- TTC39A
- UBR4
- UROD
- USP48
- VPS13D
- WARS2
- ZCCHC17
- ZMYM1
- ZNF436
- ZZZ3
q arm
- AHCTF1
- ANGPTL1
- ARID4B
- ASPM
- C1orf21
- C1orf35
- C1orf49
- C1orf74
- C1orf106
- CD5L
- CENPL
- CHTOP
- CNIH4
- CNST
- CREG1
- CRP
- CSRP1
- DDX59
- DPT
- DNAH14
- EDEM3
- F5
- FAM20B
- FAM63A
- FAM78B
- FAM129A
- FBXO28
- FCMR
- FMO3
- GBA
- GBAP1
- GLC1A
- GON4L
- HEATR1
- HFE2
- HIST2H2AB
- HIST2H2BF
- HIST2H3PS2
- HIST3H2A
- HIST3H2BB
- HPC1
- INTS3
- IRF6
- LEFTY1
- LMNA
- LYPLAL1
- MIR194-1
- MIR5008
- MPC2
- MOSC1
- MOSC2
- MPZ
- MSTO1
- NAV1
- NBPF1
- NOC2L
- NUCKS1
- NVL
- OLFML2B
- OPTC
- OTUD7B
- PGDB5
- PI4KB
- PIP5K1A
- PPOX
- PRR9
- PSEN2
- RABIF
- RN5S1
- SCAMP3
- SDHB
- SLC50A1
- SMCP
- SMG7
- SPRR1A
- SPRR1B
- SPRR2A
- SPRTN
- TARBP1
- TBCE
- THBS3
- TMCO1
- TMEM9
- TMEM63A
- TNNT2
- TOR1AIP1
- UAP1
- USH2A
- VPS45
- VPS72
- YY1AP1
- ZBED6
- ZC3H11A
- ZNF687
- ZNF648
- ZNF695
Preferred Table
| Diseases | History and Symptoms | Physical Examination | Laboratory Findings | Other Findings | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fever | Icterus | Abdominal pain | Peripheral edema | Chest pain | Jugular vein distension | Hepatomegaly | Skin rash | Edema | Spider angiomata | Serum to ascites albumin gradient (SAAG) | Ascitic fluid:
|
CBC | |||
| Hepatic causes | Cirrhosis | - | + | - | - | - | + | - | - | - | + | ≥1.1 |
|
||
| Budd chiari syndrome | - | + | - | - | - | - | + | - | - | + | |||||
| Acute liver failure | + | + | +/- | + | - | - | + | +/- | + | - | |||||
| Alcoholic hepatitis | - | - | - | - | - | - | + | - | - | - | |||||
| GI causes | Whipple disease | + | - | + | - | - | - | - | - | - | - | <1.1 |
|
||
| Peritonitis | + | - | + | - | - | - | - | - | - | - | ≥1.1 or <1.1 |
|
|||
| Pancreatitis | + (Severe pancreatitis) | - | - | - | - | - | - | + (In rare cases) | - | - | <1.1 |
|
Amylase level >100 units/L in the ascitic fluid | ||
| Cardiac causes | CHF | - | - | - | + | + | + | + (In Rt heart failure) | - | + | - | ≥1.1 |
|
||
| Pericarditis | + | - | - | - | + | + | + | - | - | - | ≥1.1 | ||||
| Renal cause | Nephrotic syndrome | - | - | - | + | - | - | - | - | + | - | <1.1 |
|
||
| Other causes | Sarcoidosis | + | - | - | - | + | - | + | + | - | - | ||||
| SLE | + | - | - | - | - | - | - | + | - | - | |||||
| TB | + | - | - | - | + | - | - | + (In Cutaneous TB) | - | - | ≥1.1 or <1.1 |
|
|||
| Hypothyroidism | - | + (Myxedematous edema) | - | - | - | + (Myxedematous edema) | - |
|
Low TSH level | ||||||
| Cancer | - | +/- | +/- | - | +/- | ≥1.1 |
|
Tumor markers for determination of the cancer type | |||||||